Marta Gil-Martin

6PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 17, 2025
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.

Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno

|Jan 02, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.

Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu

|Oct 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

Shannon N Westin, Kathleen Moore, Hye Sook Chon

|Aug 01, 2023
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).

Beatriz Tavira, Teresa Iscar, Luis Manso

Pageof 1